Eric Warren sold $209K of Mineralys Therapeutics, Inc. (MLYS) stock

Eric Warren, Chief Commercial Officer of Mineralys Therapeutics, Inc. (MLYS), sold 7,438 shares of MLYS stock worth $209K, per an SEC Form 4 filed Sep 22, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 21, 2026, 1 day before it was made public.

MLYS has moved +0.0% since the trade date, from $28.31 to $28.31 (Sep 21, 2026 close).